Stock KPRX KIORA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Kiora Pharmaceuticals, Inc.

Equities

KPRX

US49721T3095

Real-time Estimate Cboe BZX
Other stock markets
 01:23:37 2024-06-03 pm EDT 		5-day change 1st Jan Change
0.493 USD 0.00% Intraday chart for Kiora Pharmaceuticals, Inc. -8.92% -6.97%
May. 10 Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M MT
Mar. 25 Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2 From $3.50, Maintains Buy Rating
MT
HC Wainwright Adjusts Kiora Pharmaceuticals' Price Target to $3.50 From $2, Keeps Buy Rating
MT
HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2 From $7, Keeps Buy Rating
MT
HC Wainwright Raises Kiora Pharmaceuticals' Price Target to $7 From $6, Maintains Buy Rating
MT
Maxim Upgrades Kiora Pharmaceuticals to Buy From Hold, Price Target is $12
MT
Ladenburg Thalmann Reiterates Kiora Pharmaceuticals at Buy With $119 Price Target
MT
HC Wainwright Reiterates Kiora Pharmaceuticals at Buy With $10 Price Target
MT
Ladenburg Thalmann Initiates Kiora Pharmaceuticals at Buy With $6.50 Price Target
MT
Maxim Group Downgrades Kiora Pharmaceuticals to Hold From Buy
MT
HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2.50 From $3, Reiterates Buy Rating
MT
HC Wainwright Adjusts Kiora Pharmaceuticals Price Target to $3 From $5, Maintains Buy Rating
MT
Maxim Starts Kiora Pharmaceuticals at Buy With $2.50 Price Target
MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Price Target on Eyegate Pharmaceuticals to $11 From $14, Maintains Buy Rating
MT
EYEGATE PHARMACEUTICALS : Alliance Global Securities Adjusts Eyegate Pharmaceuticals PT to $10.75 From $10.25, Maintains Buy Rating
MT
EYEGATE PHARMACEUTICALS : Alliance Global Partners Adjusts Eyegate Pharmaceuticals PT $10.25 From $16.75, Maintains Buy Rating
MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Eyegate Pharmaceuticals' Price Target to $14 From $10, Keeps at Buy
MT
EYEGATE PHARMACEUTICALS : Alliance Global Partners Adjusts Eyegate Pharmaceuticals PT to $15.50 From $9.50, Maintains Buy Rating
MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Eyegate Pharmaceuticals' Price Target to $10 From $12, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KPRX Stock
  4. News Kiora Pharmaceuticals, Inc.
  5. Analyst Reco.